GGrantIndex
← Leaderboards

Jane E Freedman

Vanderbilt University Medical Center

$24,578,337
Attributed
$45,696,699
Total exposure
23
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $15M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$45,696,699 · 23

By mechanism

U24$21,099,976 · 1
R01$8,929,667 · 5
U01$3,430,478 · 1
P50$3,262,695 · 1
T32$3,249,875 · 3
UH3$3,054,612 · 1

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsFramingham Heart StudySamplingGene ExpressionCellsAtherosclerosisResearch PersonnelCommunitiesGenetic TranscriptionParticipantLinkMediatingPathway InteractionsBaseCardiovascular DiseasesProgramsBlood CirculationDiabetes MellitusInflammationCohort StudiesCohortResourcesThrombosisInflammatory

Grant awards (63)

Vanderbilt University Cardiovascular Medicine Training Program$426,335
T32 · FY2025 · HL · contact PI
ECHO Laboratory Core at Vanderbilt for Integrated Sample Biobanking and Processing$13,799,987
U24 · FY2024 · OD
Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis$771,295
R01 · FY2024 · HL
Vanderbilt University Cardiovascular Medicine Training Program$439,676
T32 · FY2024 · HL · contact PI
ECHO Laboratory Core at Vanderbilt for Integrated Sample Biobanking and Processing$7,299,989
U24 · FY2023 · OD
Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis$797,168
R01 · FY2023 · HL
Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis$533,122
R01 · FY2023 · HL
Long Non-coding RNA as Mediators of Metabolic Disease$416,224
R01 · FY2022 · HL · contact PI
Long Non-coding RNA as Mediators of Metabolic Disease$217,627
R01 · FY2021 · HL · contact PI
Long Non-coding RNA as Mediators of Metabolic Disease$201,723
R01 · FY2021 · HL · contact PI
The Effect of Behavioral Weight Loss on Circulating Extracellular RNA$125,625
R21 · FY2021 · HL · contact PI
Long Non-coding RNA as Mediators of Metabolic Disease$423,449
R01 · FY2020 · HL · contact PI
The Effect of Behavioral Weight Loss on Circulating Extracellular RNA$125,625
R21 · FY2020 · HL · contact PI
Long Non-coding RNA as Mediators of Metabolic Disease$431,142
R01 · FY2019 · HL · contact PI
Racial and Ethnic Diversity in Human Extracellular RNA$682,633
U01 · FY2018 · HL · contact PI
Transdisciplinary Training In Cardiovascular Research$363,449
T32 · FY2018 · HL
Extracellular RNAs: Biomarkers for Cardiovascular Risk and Disease$937,400
UH3 · FY2017 · TR · contact PI
Racial and Ethnic Diversity in Human Extracellular RNA$682,633
U01 · FY2017 · HL · contact PI
Extracellular RNAs: Biomarkers for Cardiovascular Risk and Disease$939,469
UH3 · FY2016 · TR · contact PI
Racial and Ethnic Diversity in Human Extracellular RNA$682,633
U01 · FY2016 · HL · contact PI
Extracellular RNAs: Biomarkers for Cardiovascular Risk and Disease$234,773
UH3 · FY2016 · TR · contact PI
Extracellular RNAs: Biomarkers for Cardiovascular Risk and Disease$942,970
UH3 · FY2015 · TR · contact PI
Racial and Ethnic Diversity in Human Extracellular RNA$682,633
U01 · FY2015 · HL · contact PI
Racial and Ethnic Diversity in Human Extracellular RNA$699,946
U01 · FY2014 · HL · contact PI
Extracellular RNAs: Biomarkers for Cardiovascular Risk and Disease$500,000
UH2 · FY2014 · TR · contact PI
Pathogen-Induced Inflammation in Platelet Function$210,692
P01 · FY2014 · AI · contact PI
Extracellular RNAs: Biomarkers for Cardiovascular Risk and Disease$500,000
UH2 · FY2013 · TR · contact PI
Pathogen-Induced Inflammation in Platelet Function$230,976
P01 · FY2013 · AI · contact PI
Pathogen-Induced Inflammation in Platelet Function$297,439
P01 · FY2012 · AI · contact PI
HIGH-THROUGHPUT GENE EXPRESSION$219,711
P01 · FY2011 · HL · contact PI
Pathogen-Induced Inflammation in Platelet Function$158,162
P01 · FY2011 · AI · contact PI
Inflammation, Innate Immunity and Thrombosis$700,722
P50 · FY2010 · HL · contact PI
Gene Expression and Thrombosis in a Community Based Cohort Study$428,188
R01 · FY2010 · HL · contact PI
Multidisciplinary Training in Cardiovascular Research$395,160
T32 · FY2010 · HL · contact PI
Gene Expression and Thrombosis in a Community Based Cohort Study$283,128
R01 · FY2010 · HL · contact PI
Pathogen-Induced Inflammation in Platelet Function$169,756
P01 · FY2010 · AI · contact PI
PROTEOMICS OF TOLL-LIKE RECEPTOR 2 & INTRACELLULAR FACTOR XIIIA IN PLATELETS$4,049
P41 · FY2010 · RR · contact PI
Gene Expression and Thrombosis in a Community Based Cohort Study$717,694
R01 · FY2009 · HL · contact PI
Inflammation, Innate Immunity and Thrombosis$680,199
P50 · FY2009 · HL · contact PI
Multidisciplinary Training in Cardiovascular Research$368,433
T32 · FY2009 · HL · contact PI
PROTEOMICS OF TOLL-LIKE RECEPTOR 2 & INTRACELLULAR FACTOR XIIIA IN PLATELETS$2,344
P41 · FY2009 · RR · contact PI
Gene Expression and Thrombosis in a Community Based Cohort Study$709,795
R01 · FY2008 · HL · contact PI
Multidisciplinary Training in Cardiovascular Research$663,003
T32 · FY2008 · HL · contact PI
Inflammation, Innate Immunity and Thrombosis$647,117
P50 · FY2008 · HL · contact PI
PROTEOMICS OF TOLL-LIKE RECEPTOR 2 & INTRACELLULAR FACTOR XIIIA IN PLATELETS$1,951
P41 · FY2008 · RR · contact PI
Gene Expression and Thrombosis in a Community Based Cohort Study$758,503
R01 · FY2007 · HL · contact PI
Inflammation, Innate Immunity and Thrombosis$641,023
P50 · FY2007 · HL · contact PI
PROTEOMICS OF TOLL-LIKE RECEPTOR 2 & INTRACELLULAR FACTOR XIIIA IN PLATELETS$3,232
P41 · FY2007 · RR · contact PI
Multidisciplinary Training in Cardiovascular Research$593,819
T32 · FY2006 · HL · contact PI
Inflammation, Innate Immunity and Thrombosis$593,634
P50 · FY2006 · HL · contact PI
PROTEOMICS OF TOLL-LIKE RECEPTOR 2 & INTRACELLULAR FACTOR XIIIA IN PLATELETS$1,599
P41 · FY2006 · RR · contact PI
eNOS Polymorphisms, Aging and Platelet Function$282,625
R01 · FY2005 · AG
PROTEOMICS OF TOLL-LIKE RECEPTOR 2 &INTRACELLULAR FACTOR XIIIA IN PLATELETS$1,595
P41 · FY2005 · RR
eNOS Polymorphisms, Aging and Platelet Function$282,625
R01 · FY2004 · AG
eNOS Polymorphisms, Aging and Platelet Function$282,625
R01 · FY2003 · AG
PLATELET-DERIVED NITRIC OXIDE AND HEMOSTASIS$266,189
R01 · FY2003 · HL
eNOS Polymorphisms, Aging and Platelet Function$282,625
R01 · FY2002 · AG
PLATELET-DERIVED NITRIC OXIDE AND HEMOSTASIS$258,437
R01 · FY2002 · HL
PLATELET-DERIVED NITRIC OXIDE AND HEMOSTASIS$192,327
R01 · FY2001 · HL
PLATELET-DERIVED NITRIC OXIDE AND HEMOSTASIS$27,415
R01 · FY2001 · HL
CALCIUM, AGING, AND HYPERTENSION$202,737
R01 · FY2000 · AG
PLATELET-DERIVED NITRIC OXIDE AND HEMOSTASIS$163,004
R01 · FY2000 · HL
REDOX STATUS AND ANTIOXIDANTS IN PLATELET FUNCTION$116,640
K08 · FY2000 · HL